Inspire Medical Systems
Manufacturer of the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea..
HQ location
Golden Valley, United States
Website
Launch date
Employees
Market cap
$3.9b
Enterprise value
$3.6b
Share price
$129.77 INSP
Recent deals
loading funding rounds…
Medtronic(exited)
Amzak Capital Management(exited)
Synergy Life Science Partner(exited)
TGap Ventures(exited)
Aperture Venture Partners(exited)
OrbiMed(exited)
Aperture Ventures Partners(exited)
U.S. Venture Partners(exited)
Kleiner Perkins(exited)
Mudit K. Jain, PhD(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 102 % | 75 % | 53 % | 28 % | 18 % | 17 % | 16 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (17 %) | (10 %) | (3 %) | 8 % | 21 % | 23 % | 25 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (18 %) | (11 %) | (3 %) | 7 % | 7 % | 9 % | 11 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 16 % | 17 % | 19 % | 14 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
